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Abstract
In 2012, opioid prescriptions exceeded 250 million, which is equivalent to providing a
prescription to every adult in the United States. Prescription opioids have contributed to
over 100,000 deaths since the late 1990s with the greatest impact among adults 35
through 54 years of age. The purpose of this doctoral project was to introduce an
evidence-based screening tool that will identify patients who are at risk of opioid misuse
and aid in the development of the most effective treatment plan to manage chronic pain
and avoid abuse. The Screener and Opioid Assessments for Patients with Pain (SOAPP),
a screening tool, was given to 100 participants, both males and females between the ages
of 25 and 65, in an outpatient pain clinic. The data collection method was a
questionnaire consisting of 14 questions designed to predict behaviors of people using
opioids for chronic pain. Participant questionnaire responses on the Likert-5-point scale
of 0 (Never), 1 (Seldom), 2 (Sometimes), 3 (Often), and 4 (Very Often) were totaled
with a score of 7 or above indicating a high risk for abuse. Once the SOAPP data were
obtained scores were calculated and grouped into categories of low or high risk for
opioid misuse or abuse. Results indicated that 25% of the participants scored at high risk
for opioid misuse (22% were female and 27% male) implying that there was a need for
additional monitoring by the physician and nurse practitioner. The mean age for high
risk was 51 and for low risk 54. Pain management providers play a crucial role in the
effectiveness and success of the patient’s treatment. Positive social change may occur
when assessment tools such as the SOAPP are used in the evaluation and management of
patients with chronic pain and addiction.
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Section 1: Introduction
Introduction
Pain is one of the major causes of disability, work loss, and health care cost in the
United States (Hayden, Cartwright, Riley, and Vantulder, 2012). Patients with chronic
pain are often seen in clinical settings devoted to pain management. There has been an
increase in abuse and misuse of opioids for chronic pain patients in the United States
(Manworren & Gilson, 2015). According to the National Institute of Health (NIH), over
125 million people in the United States suffered with some type of pain (NIH, 2015). It is
expected that 70% of those people treated their pain with opioids prescribed to a friend or
family member (Arnstein, & St. Marie, 2010). Overprescribing of opioids for pain
management has contributed to a noticeable increase in opioid addiction, death caused by
overdose, and heroin use (American Academy of Orthopaedic Surgeons [AAOS], 2015).
The clinical dilemma is how to treat chronic pain while avoiding opioid abuse and
misuse. Sullivan, Korff, Banta-Green, Merrill, and Saunders (2012) describe deviant
patient drug-related behaviors such as obtaining prescriptions from multiple providers,
forging prescriptions, and increasing opioid dosages. These behaviors could potentially
indicate addictive characteristics or a possible manifestation of poor pain control.
According to the Obama Administration, prescription drug abuse has had an agonizing
impact on individuals, families, healthcare providers, and law enforcement in the United
States, and it is imperative to take action against this epidemic (The White House, Office
of the Press Secretary, 2015).
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Overprescribed opioid medications are becoming the most frequently misused
controlled substances nationally (Stayner & Copenhaver, 2012). According to the Benzon,
Liu, Fishman, & Cohen, (2011), pain related laws have not kept current with advances in
medical and scientific understanding. The legislative bodies have created laws that are
broad and general, with the expectation that they will be interpreted by the regulatory
agencies. However, this has not been the case, and implications of overprescribing
practices with opioids remains a concern.
This practice improvement project will introduce the utilization of an
evidencebased screening tool to assist providers in recognizing those at risk for opioid
abuse or misuse and can also be used to help guide the development of the individualized
plan of care for this patient population. This follows the recent work completed by the
Choosing Wisely Campaign (2014) committee which recommends that healthcare
providers not prescribe opioids until after discussing risks, such as addiction, with the
client. Educating patients on risk factors increases their awareness of opioid abuse and
allows the patient to become involved in their plan of care (American Society of
Anesthesiologists [ASA],
2014). Ultimately, it is the healthcare provider’s decision whether to prescribe opioids as
well as the dosage when prescribed. Utilization of tools such as Screener and Opioid
Assessments for Patients with Pain (SOAPP; Inflexxion, Inc., 2008) can assist in
determining those who may be at risk of misuse and, subsequently, aid in the development
of a treatment plan that will assist in the prevention of addictive behaviors that could
promote misuse. This can contribute to the prevention and treatment of opioid abuse.
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Problem Statement
In 2012, opioid prescriptions exceeded 250 million, which is equivalent to
providing one prescription to every adult in the United States (The White House, 2015).
According to Franklin (2014), prescription opioids have contributed to over 100,000
deaths since the late 1990s, with the greatest impact among adults 35 through 54 years of
age. The shortage of physicians specializing in pain management has contributed to
ineffective opioid prescribing practices (Harle, Bauer, Hosang, Cook, Hurley, and
Fillingim, 2015). It is also noted that primary care doctors become distressed when trying
to manage patients with chronic pain due to the worries about opioid abuse, misuse, and
diversion (Harle et al., 2015). Primary care physicians have a limited amount of training in
pain management (Jeffery, Butler, Stark, & Kane, 2011) and have time restraints when
caring for patients with chronic pain (Abbo, Zhang, Zelder, and Huang, 2011), which
plays a major role in effective pain management.
The setting for this study is an outpatient pain clinic, which sees approximately
6,000 patients yearly, averaging about 500 patients per month. The patients have been
diagnosed with chronic pain and a majority are currently receiving opioids for pain
management. With the concern over the rising number of deaths, abuse, and misuse of
opioids, the need for a specific assessment tool was identified by the physician who is the
key stakeholder. The utilization of a screening tool could be helpful in identifying patients
at risk for addictive behaviors which would alert clinicians to monitor patients more
closely and provide specific education or different interventions. Based on the clinician’s
findings, they may recognize a need to alter their plan of care including dosage
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adjustments, thereby producing better pain management results and a decrease in the
potential misuse of opioids.
Background
The institutions referenced to address this problem are the Centers for Disease
Control and Prevention (CDC) and Department of Health and Human Services (HHS).
According to the CDC, there has been an increase in deaths due to opioid overdose. It has
been estimated that 6 to 8 million Americans use opioids for noncancer pain (Baldini, Von
Korff, & Lin, 2012). The CDC will invest $8.5 million on (a) the development of tools
and resources to help inform providers about effective opioid prescribing; (b) track data
on prescribing trends; (c) research, develop, and evaluate clinical quality improvement
measurements and programs on opioids prescribing; and (d) improve public understanding
of the risks and benefits of opioid use (The White House, 2015). The HHS will invest
$100 million in Affordable Care Act funding to focus on the assurance of prescribing a
product of suboxone and narcan for the treatment of opioid dependency. HHS plans to
make these medications accessible to community health centers across the country (USG,
2015).
Opioid dependence continues to be a chronic problem not only in the United
States, but in other countries as well. In 2010, statistics showed that there were 15.5
million opioid dependent people globally (Degenhardt et al., 2014). South Asia was
identified as having the greatest number of opioid-dependent people (4 million), with East
Asia, North Africa, and the Middle East, and Western Europe having 1.3 million each
(Degenhardt et al., 2014). Studies have also indicated that people in higher income
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countries continue to use opioids despite the significant impact it has on them socially,
such as arrest and imprisonment for crimes related to theft of property and drugs, and the
health problems that it causes, such as fatal and nonfatal opioid overdose (Degenhardt et
al., 2014).
Opioid is a pain analgesic that is very powerful and highly addictive (Dixon &
Peirson, 2017). Some of the prescription drug classifications of opioid pain medication
include oxycodone, hydrocodone, methadone, and morphine, which are used to treat short
and long term pain and have been linked to the increasing drug overdose deaths in the last
ten years (HHS, 2015). The death rate for drug poisoning from opioid pain medication has
quadrupled from 1999 to 2013 (HHS, 2015).
In the United States, addiction and abuse of opioid drugs continues to be a public
health problem and a challenge. It affects approximately 5 million people and has led to
nearly 17,000 deaths annually (Dixon & Peirson, 2017). The mortality rate from drug
overdoses has continued to rise over the last twenty years and has been identified as the
primary reason for injury mortality in the United States (HHS, 2015).
In addition to mortality, there have been other adverse medical events linked to
prescription opioid abuse over the last several years. There has been an increase in
emergency room visits which were associated with abuse and misuse of prescription drugs
with over 1.4 million pharmaceutical events, 420,000 involving prescription opioids
(HHS, 2015). The literature has shown that people who are at the highest risks for opioid
overdose are Alaskan Natives, White and American Indian men, adults between the age of
45-54, people who live in rural areas who take daily high doses of opioid pain medication,
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analgesics, and people who obtain several prescriptions for controlled substance from
different providers (HHS, 2015).
The misuse of prescription drugs continues to have a significant impact on
communities throughout the country (Bureau of Justice Assistance [BJA], 2015).
According to the CDC, this fatal prescription analgesic epidemic affects communities in
every state (CDC, 2013). Communities are being targeted for criminal behaviors that are
associated with prescription drug abuse and misuse, including home and business
burglaries and robberies of pharmacies, clinics, and doctors’ offices. This has affected
every community at the local, state, national and global levels necessitating interventions
to help alleviate the drug dependency (BJA, 2015). It is clear that the impact of the misuse
of opioids calls for immediate action. The significance of having a tool such as SOAPP,
which helps identify potential opioid abusers, would provide useful knowledge for
physicians to consider when developing a plan of care and treatment. Utilization of
screening tools for opioids such as urine drug screen, opioid risk assessment screen,
standardized pain scales, and prescription drug monitoring programs may assist in
assessing those at risk of possible opioid abuse. Other barriers include time-constraints,
lack of information, negative approaches toward prescribing opioids, and inadequate
assessment skills (Harle et al., 2015). Pain management providers play a crucial role in the
effectiveness and success of the patient’s treatment, and the use of such tools can assist in
effective program planning to meet both the pain and addiction issues of the patient.
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Purpose
The purpose of this doctoral project was to introduce an evidence-based screening
measure that will identify patients with the potential to abuse and misuse opioids into a
pain management clinic practice for use with patients where it has been determined that
the most effective treatment is the use of opioids to manage their chronic pain. This tool
may assist clinicians in identifying patients who are at risk of addiction and alert the
clinician to modify their treatment plan, if necessary. Identifying patients at risk for opioid
abuse and/or dependence can alert the clinicians to provide education and intervention
programs. The tool may further inform the provider of the need for alternative or modified
pain management strategies. For patients who are identified as either abusing or misusing
opioids, other strategies can be initiated, such as providerclient contracts, depression
screenings, and monitoring of opioid use.
The screening measure used for the patients in the study was the SOAPP, which is
found in Appendix A (Inflexxion, Inc., 2008). SOAPP is a tool the clinician used to assess
the potential that a patient would likely abuse opioids. SOAPP has 14 questions designed
to predict behaviors of people using opioids for chronic pain. This screening measure
complements current risk assessment practices and the clinician’s ability to assess patients
risk for opioid misuse (Butler, Budman, Fernandez, Fanciullo, & Jamison, 2010).
According to Butler et al. (2010), this tool is much more effective than other methods that
are being used currently, and it gives the physicians an awareness that patients are at risks
for deviant behaviors (Butler et al., 2010). The SOAPP should be used only with patients
who have chronic pain and are being considered for long-standing opioid therapy. The use
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of a broader base approach would not be applicable for all patients with chronic pain. This
doctoral project has the potential to introduce a valid pain measurement tool to the
healthcare community and add to the literature on evidencebased practice in pain
management.
Nature of the Doctoral Project
This evidence-based practice project utilized the Rosswurm and Larrabee (1999)
six stage model to facilitate a shift from traditional and intuition-driven practice to
improvement with evidence-based changes into practice. The six stages of the model are
as follows: (a) assess the need for a change in practice, (b) link the problem with
interventions and outcomes, (c) synthesize the best evidence, (d) design a change in
practice, (e) implement and evaluate the change in practice including processes and
outcomes, and (f) integrate and maintain the change in practice using diffusion of
innovation state strategies.
Assess the Need for Change in Practice
The physician and nurse practitioner manage a client load of approximately 1,226
patients per quarter with chronic pain in a clinic located in an urban area of Indiana. They
requested scholarly assistance in improving care by introducing an evidence-based
screening instrument into the practice.
This is a private practice setting primarily focused on musculoskeletal medicine
and rehabilitation. The patient age range is from 30 to 80. The leading diagnoses are
chronic low back pain, neck, hip and knee pain, fibromyalgia, and migraine. The majority
of patients are treated with opioid medications to help aid in pain management. The
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primary goal of the pain center is to restore maximum functioning lost through injury,
illness or disabling conditions. The center treats numerous medical conditions and
provides various treatment options, such as rehabilitation, pain management, alternative
therapies, prolotherarpy, electrodiagnosis interventional procedures, and worker’s
compensation and disability evaluation. The physician director is committed to the
common good by helping clients achieve optimum pain management by addressing pain
issues/concerns, screening, treating the individual as a whole and providing education, and
offering alternative treatment and rehabilitation to help achieve a better quality of
life.
The primary aim of this study was to utilize assessment tools to identify clients
who are at risk of opioid misuse or addiction and those who are currently misusing or
abusing opioids and provide the most effective treatment plan to manage pain and avoid
abuse. The misuse of opioids has been identified in the literature as one of the challenges
of primary care practice (Harle et al., 2015).
Link the Problem with Interventions and Outcomes
Chronic pain and prescription opioid abuse continue to place a burden on society,
patients, and doctors. (Sehgal, Manchikanti, & Smith, 2012). Over the last twenty years
there has been a dramatic increase in chronic opioid use for treatment of noncancerous
pain, which has resulted in a higher rate of abuse of prescribed opioids and unintentional
overdose (Sehgal et al., 2012). A review of the literature suggests that using a validated
screening tool can provide an additional method for managing patients on opioid therapy
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and assist in addressing problematic issues as they occur. Recognizing and predicting risk
could be of great benefit in reducing the risk of iatrogenic addiction (Sehgal, et al., 2012).
One tool that has been utilized in screening during opioid therapy is the SOAPP.
This tool can help doctors monitor any abnormal characteristic behaviors of misuse and
abuse that are related to patients receiving opioid therapy for long term use for
noncancerous pain (PainEDU, n.d.). According to Akbik et al., (2006) the SOAPP
screening tool reveals factors such as history of substance abuse, legal problems, craving
medications, heavy smoking, and mood swings that may indicate probability to misuse or
abuse opioid medications (Akbik et al., 2006). The SOAPP instrument is a questionnaire
which is simple and easy to use. It was designed based on important concepts that are
likely to predict which patients on chronic opioid therapy will require additional or lesser
monitoring. The questionnaire contains 14 items with a 5-point grading scale and takes
less than eight minutes to complete. The SOAPP score risk is identified by the “cutoff
values”: a score of 7 or greater identifies approximately 91% of those who are at high risk;
a score less than 7 indicates a lower risk (Inflexxiion, 2008). Once the risk score is
determined, the clinicians can identify which patients need more or less monitoring and
can address concerns with the patients and update the plan of care with the appropriate
interventions as indicated.
The Pain Management Center of Brigham and Women’s Hospital tested the
validity and reliability of the SOAPP tool using data collected from a group of chronic
pain patients from five pain clinics across the country. The 24-item SOAPP tool,
developed from the consensus of 26 pain and addiction experts, was administered to 175
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patients who were taking opioids for chronic pain. Of the 24 items, 14 SOAPP items
appeared to predict subsequent aberrant behaviors. Based on the reliability and predictive
validity results, SOAPP was viewed as a promising screening risk potential tool for
substance misuse among patients with chronic pain (PainEDU, 2016).
Synthesize the Best Evidence
According to PainEDU (2016), clinics often mention that they do not have an
opioid risk assessment screening tool as part of their intake process. Due to the challenges
with opioid abuse and misuse, clinics are finding that it is crucial to include an opioid risk
assessment as part of their screening process. PainEDU has identified the
SOAPP screening tool as an effective tool to incorporate as part of the intake process
(PainEDU, 2016). The SOAPP tool was chosen to be used in this outpatient pain clinic
due to the support in the literature and the significance of the design, which addresses the
potential for opioid abuse or misuse. This tool helps clinicians improve their ability to
assess patients’ risk for opioid abuse and can assist with the management of their
treatment modality and plan of care (Butler et al., 2010).
According to Butler et al. (2010), the sensitivity of a tool for screening may be
more important than the specificity because those screened might have problems
managing their medications. Butler et al. suggests that medical decisions not be made
merely on basis of the SOAPP screening, however.
Design a Change in Practice
The SOAPP screening tool was used with new admissions and routine visits by
established patients. The SOAPP questionnaire was given orally to 100 consecutive
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patients in a private setting. The data was scored according to their answers in nominal
ratio. The patients who were identified as high risk were recommended for close
monitoring by the clinicians and a review of their plan of care.
Implement and Evaluate the Change in Practice Including Processes and Outcomes
For a period of two weeks, the investigator reviewed charts of patients on the
appointment list for the following day. Those with a medical diagnosis of pain and
currently taking opioids had the survey tool attached to their intake form. The patients
were requested to complete the form prior to seeing the physician.
The tool was reviewed by the investigator and a score placed on the chart to alert
the clinician. Results were collected for a total of 100 patients in a table for descriptive
statistics. Participants were not identified by name; rather, each was assigned a unique
identifier for the data analysis. The clinician indicated on the summary tool whether the
tool influenced the plan of care. This information was used to determine the impact on
clinician behavior.
The descriptive data analysis included patients between the ages of 25 and 65 who
were receiving opioid medication for noncancer pain. This analysis will be used for health
planning purposes regarding the education and promotion of interventions for patients
with the potential for opioid abuse (Friis & Sellers, 2014).
Integrate and Maintain the Change in Practice Using Diffusion of Innovation State
Strategies
Once the data was obtained from the SOAPP questionnaire, the scores were
calculated and analyzed as being a low or high risk for opioid misuse or abuse. The
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physician or the nurse practitioner was notified in person. The results and identifiable
interventions and plan of care were addressed with staff identified as key stakeholders.
Significance
The potential implication for this project is to introduce the utilization of a reliable
tool to assess a patient’s risk of potential abuse or misuse of opioids as part of the
development of pain measurement and an individualized plan of care for pain
management. Once this tool is implemented, the clinicians can review the medication and
adjust the plan of care accordingly. Positive social change will result from identifying at
risk patients, which may help reduce the potential for opioid misuse and abuse.
Summary
The lack of evidence-based pain measurement tools and the shortage of physicians
specializing in pain management has contributed to ineffective opioid prescribing
practices and to misuse and abuse of opioid medication (Harle, et al., 2015). The
incorporation of the SOAPP pain measurement tool into a chronic pain practice has the
potential to facilitate the providers’ decision making and clinical management of chronic
pain patients. In Section 2 I will detail the concepts, theories, and the change model and
provide additional literature on the employment of the SOAPP tool with opioid use.
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Section 2: Background and Context
Introduction
This evidence-based practice project introduced the use of the SOAPP
questionnaire in identifying chronic pain patients who are either at risk of or currently
abusing or misusing opioids. Pain is one of the major causes of disability, work loss, and
health care costs in the United States (Hayden et al., 2012). The purpose of this project
was to introduce a reliable pain measurement tool to facilitate providers in developing an
individualized plan of care for pain management.
Published Outcomes and Research
The databases and search engines that were used in the literature search included
the Cochrane Database, Ovid Nursing, CINANL, SAGE, MEDLINE, and Google
Scholar. The key search terms used were opioid abuse and misuse, pain management,
SOAPP, overprescribing, prescription drugs, opioid screening tools, federal and state
guidelines, nursing role in pain management, Roy Adaptation Model, the CDC website, and
fact sheets from the National Institutes for Mental Health.
The literature reviewed was published within the last five years, and the sources
included Journal of American Medical Association, American Academy of Pain
Medicine, Pain Physician, Institute of Medicine, The Annual Review of Public Health,
Nurse Practitioner Healthcare Foundation, Journal of Pain and Symptoms, PubMed
Central, Journal of Addiction Medicine, U.S. Government Fact Sheets, and the American
Journal of Nursing. This search resulted in a comprehensive review of the literature to
address the practice focus question.
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Drug abuse and addiction is a major social and global health problem. One factor
is the treatment of pain. In the United States, there are approximately 100 million
Americans who suffer from chronic pain (Why do people get addicted to opioids?, 2016).
The increase has occurred over a 25-year period from nearly 75 million in the 1990s to
nearly 206 million in 2013 (Zimic & Jukic, 2012). Other factors contributing to this
problem are family risk factors, childhood experiences, family boundaries, and social
influence by peers, friends, schools, and surrounding environments (Georgas, Berry, van
der Vijver, Kagitçibasi, & Poortinga, 2006).
Some professionals believe the prescription painkiller problem in the United
States is the result of opioids being prescribed in combination with other medications,
along with the influence of pharmaceutical advertisements. For some, drug abuse begins
with a prescribed opioid for a valid medical reason and then feelings of relief lead to the
enraptured effect of the drug (Why do people get addicted to opioids? 2016). The dangers
of abuse can occur from the use of all forms, such as pills taken orally, snorting, injecting,
or a combination of pills and alcohol with other drugs. Additionally, many people in the
community are going from prescriptive opioid abuse to the use of heroin. Scientists
believe the physical changes to the brain explain the neurotic and damaging behavior of
individuals addicted to opioids. When tolerance to these drugs begins to function as a
normal process, the body is unable to control the impulses needed to mitigate harsh
consequences (Why do people get addicted to opioids? 2016).
With the ongoing trend of opioid abuse and misuse, it is essential that monitoring
programs be put in place to help reduce the problem. According to Irvine et al. (2014)
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prescription drug monitoring programs (PDMPs) are relatively new but are a helpful tool
to aid in the management of prescribed controlled substances. There appears to be little
known about the kinds of clinicians who make the most use of PDMPs, how they are
integrated into the work process, or how clinicians and patients react to evidence. More
inquiry is necessary to lessen prescription abuse of drugs and overdoses, which have
become widespread in the United States, and to explore the potential for the
implementation of PDMP to offset the epidemic (Irvine et al., 2014).
A statewide survey was conducted with approximately 1,000 providers, which
consisted of clinicians from primary care and emergency rooms as well as pain and
addiction specialists. The primary goal was to see how clinicians make use of the PDMPs,
how the data is incorporated into the work place, and how the patients and clinicians
respond to the information. This survey revealed that almost 90 percent of clinicians
reported using the PDMP when they suspected a patient of diversion or abuse. However,
less than half would check every new patient or when they prescribed a controlled
substance. Approximately 50% of patients were referred to substance abuse and mental
health clinics, and about 30% were discharged from the clinician’s practice (Irvine et al.,
2014). The survey also identified that clinicians reported a range of patient behaviors such
as denial and anger, and almost three quarters of the patients did not come back. Some
patients did ask for help with dependence and drug addiction. At least 61% of clinicians
thought more training in PDMP would be useful in identifying abuse of substances and
provide different ways to control medications, strategies for confrontation diffusion, and
methods of chronic pain management (Irvine et al., 2014).
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According to Irvin et al., (2014) physicians who used PDMP for any reason found
that through interviews, the tool served as a means of communication between patient and
providers. This enhanced the opportunity for dialogue regarding topics of education,
compulsion, dependence, and ways and approaches to improve pain management. In one
physician’s summation, this tool has a ways to go in terms of helping to find out what is
the best way to make decisions and combining them into a process (Irvin et al., 2014).
Concepts, Models, and Theories
Rosswurm and Larrabee’s (1999) model of change represents a shift from the
traditional way nurses practice to implementing the new paradigm of evidence-based
practice in the clinical setting. Evidence-based practice is a model which guides
practitioners through research literature and theory. According to Institute of Medicine
(IOM) the way nurses were taught in the 20th century is no longer adequate for the health
care in the 21st century (IOM, 2010). The patients have become more complex and require
a higher standard of care. Nurses’ roles will expand to managing information systems and
mastering technological tools while coordinating and collaborating care across teams of
health providers. The nurse must achieve higher levels of education that is research and
evidence-based and develop competence in leadership, health policy, system
improvement, and collaboration (IOM, 2010).
This model of care integrates the process of change through assessment of needs
and adoption of new protocols that are evidence-based to minimize the discomfort
clinicians and patients experience when it comes to questions, data, preferences, and new
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research (Rosswurm & Larrabee, 1999). These identifiable changes can help stakeholders
become aware of potential changes that are needed to achieve the best outcome
(Rosswurm & Larrabee, 1999).
There have been significant changes in today’s health care systems’ focus on
integrating evidence-based practice into health care to help improve patient safety, care,
and cost containment while providing a better outcome. Also, research has identified that
with the diversity of patient’s needs, it is critical that nurses be prepared to function as a
leader and advance science that benefits patients and improves the capacity of the health
professional to deliver safe, effective, and patient-center care (IOM, 2011).
Relevance to Nursing Practice
Over the past 20 years the prevalence of chronic pain and the rising costs of
healthcare have contributed to an opioid epidemic with serious consequences to morbidity,
mortality, and crime levels (Manchikanti et al., 2012). There are more deaths from opioid
analgesics than from motor car crashes, suicides, and heroin and cocaine combined
(Manchikanti et al., 2012). There is a significant relationship between the sale of opioid
pain relievers and the rise in deaths. However, deaths are almost 60% in patients with
prescriptions based on guidelines by medical boards and nearly 40% in the form of
numerous prescriptions, doctor swapping, and drug diversion (Manchikanti, et al., 2012).
Obstacles to preventing opioid deaths include insufficient knowledge, safety perceptions,
and incorrect beliefs regarding handling of pain by clinicians.
According to the AAOS (2015), opioid overdose is now the leading cause of
accidental death in young adults and contributes to a greater risk of postoperative
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expiration. The AAOS suggests that surgeon and members of the team should explain to
extended families and patients, that opioid protocols cannot be violated and that there
should be better control established.
However, the diversion tactics of opioids from friends and family members who
have appropriate prescriptions are a major part of the abuse of prescribed opioids (AJN,
2015). Nurses are considered trusted and influential in educating the family to help
decrease the occurrence and possibilities of deadly consequences of prescription opioids.
The advanced nurse practitioner and clinic nurses have a role in reducing opioid
diversion through patient monitoring, screening, education and alternative medications
(AJN, 2015). There are large gaps in knowing how much opioid medication is needed to
help manage a patient’s pain. Nurses are at the forefront and have the opportunity to
provide clients with strategies that involve patient education on the dangers of diverting
medication to other areas, securing, disposing and monitoring efforts to help reduce their
availability of opioid medications (AJN, 2015).
The practice improvement project introduces an opioid screening tool, the Screener
and Opioid Assessment for Patients with Pain (SOAPP). The clinic population where this
tool was used is representative of the many patients seeking treatment for pain in the
musculoskeletal area of the body and restoration of functions lost due to injury, sickness,
or debilitating conditions. For these patients treated with opioid medications, the SOAPP
screening will help focus on identifying the patients who could be misusing or becoming
addicted to opioids.
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According to Moore, Jones, Browder, Daffron and Passik, (2009), substance abuse
has a negative impact on society and does affect millions of people in the United States.
Prescriptive opioids are critical to managing pain, therein lies a fear that aberrant drug
associated behavior, addiction and abuse are reasons why under treatment of some cancer
patients is prevalent (Moore et al., 2009).
A survey by Moore et.al, (2009) used a sample of patients 18 years and older in the
study of females and males using a risk assessment by completing a questionnaire, with
the SOAPP, Opioid Risk tool (ORT), the Diagnosis, Intractability Risk, and Inventory
(DIRE), and a team psychologist. Several pain management centers measure risk by using
only one of the evidence-based tools to predict and conclude probable risk of abuse when
recommending opioids for pain (Moore et al., 2009).
According to Butler (2009), the SOAPP assessment tool helps provide information
on how much monitoring is needed or required based on the cut-off score predictor. The
SOAPP value proposition is that there is sensitivity in the test. In subsequent studies, the
SOAPP is better at the identification of high risk patients rather than the identification of
who is at low risk (Butler, 2009). Moore et al. (2009) noted that the cut-off score which
measured participants” greater than 6 on the SOAPP, or less than 14 on the DIRE, were
considered high risk, whereas, scoring from 4-7 or greater than 7 on the ORT were
considered medium and high risk, respectively” (Moore et al., 2009).
Moore et al. (2009) compared three tools of assessment for predicting aberrant
behaviors and whether validation can result in opioid medications suspension. The
SOAPP was rated the best of the screening tools with its specifics of behavior, length, and
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opacity and the high sensitivity and values of these measures. This tool was noted to be
very useful when it came to time of completion and management of a large volume in the
clinical site, which can help with patient and staff load (Moore, 2009). The authors did
note that the study was small and more research is needed to make a knowledgeable
choice over another when determining specific treatment approaches and medical
techniques to help with treatment (Moore al et., 2009).
Summary
There is a need to include reliable pain measurement tools to facilitate providers in
developing an individualized plan of care for management. Opioid abuse crosses all ages,
ethnic groups, economic situations, and education levels. Evidence-based practices and
protocols require adherence to reach the ultimate goal and foster a plan to eradicate the
social, psychological, health and economic hardship of opioid abuse.
According to American Association of Colleges of Nursing (AACN) Essentials,
the advanced nurse practitioner must utilize evidence based knowledge to the highest
standard of practice to facilitate change effectively to benefit patients’ daily needs and
provide for a better outcome (ACCN, 2006). The role of the DNP encompasses the role of
practitioner, educator, and activist for the purpose of implementing change in the
community. Section two will provide additional detail on the implementation and data
analysis plan.
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Section 3: Collection and Analysis of Evidence
Introduction
There has been an increase in abuse and misuse of prescription drugs for chronic
pain patients in the Untied States (Manworren & Gilson, 2015). Overprescribing of
opioids for pain management has contributed to a noticeable increase in opioid addiction
and death caused by overdose and heroin use (Kolodny et al., 2015). According to Reuben
et al. (2015), over 100 million people in the United States suffer from chronic pain. A
suspected 70% of those individuals treated their pain with opioids prescribed to a friend or
family member (Arnstein &St. Marie, 2010). The shortage of physicians specializing in
pain management has contributed to ineffective opioid prescribing practices and either
misuse or abuse (Harle et al., 2015). The purpose of this project was to implement an
evidence-based screening measure for opioid abuse and misuse for chronic pain patients
who take opioids to manage their pain.
Practice-Focused Question
The practice focused question was: Does the utilization of an evidence-based
screening tool assist the clinician in an out-patient pain management setting in identifying
chronic pain patients who are either at-risk of or who are abusing or misusing opioids, and
does it result in a modification of routine therapy?
Sources of Evidence
The collection and analysis of evidence from the SOAPP screening tool scores
patients who are at risk for opioid misuse, thus alerting the clinician to monitor patients
more closely. According to Butler et al., (2010), a cross-validation study was conducted
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and showed that the SOAPP tool was a reliable and valid screening tool to use for the risk
of aberrant drug-related behavior among patients with chronic pain (Butler et al., 2010).
SOAPP was developed with a grant from the National Institutes of Health and an
educational grant from Endo Pharmaceuticals (Inflexxion, 2008). It was designed based on
an expert consensus model to help clinicians identify those patients that may require more
or less monitoring while on opioid therapy. The SOAPP is a self-report measure that
consists of 24 items, but only 14 are used for scoring. The scoring is based on a
Likert 5-point scale of 0 (Never), 1 (Seldom), 2 (Sometimes), 3 (Often), 4 (Very Often).
The cut-off value is 7; the score of 7 or above indicates a high risk for abuse and the need
for additional monitoring for treatment for opioid therapy (Akibik et al., 2006). A study
conducted with 48 participants in Tennessee by Moore, Jones, Browder, Daffron, and
Passik, (2009) compared three common risk tools for predicting at-risk aberrant
drugrelated behavior; the ORT, DIRE, and SOAPP. The study concluded that the SOAPP
was more sensitive in identifying high-risk aberrant behavior, required less time to
complete, and took only one minute to score, making it a very practical screening tool to
use, even for large clinical settings.
Evidence Generated for the Doctoral Project Study Design
The study was a quantitative descriptive study using a convenience
sample population which included all new and established patients who were prescribed
opioid medications for noncancer pain. The patients who were prescribed opioid
medication were screened to see if the opioid risk assessment tool was effective in
identifying an atrisk population for opioid abuse and misuse and provided useful
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information for the clinician’s management plan in this outpatient pain management
clinic. The exclusion criteria was anyone under the age of 18, those with an altered mental
status, anyone having the inability to speak English, and those who were not currently
taking opioid medications.
Setting and Sample
The setting was an outpatient pain clinic with designated private rooms for
providing the questionnaire. The questionnaire was given to the patients prior to the
clinicians entering the room. The participants were selected from an established outpatient
pain clinic; therefore, all patients were taking opioid medications. The sample size
consisted of 20% of the monthly population of 500, which resulted in a sample size of n =
100. The sample included both males and females between the ages of 25 and 65 who met
the requirement of short- and long-term opioid use for noncancerous pain.
Data Collection
The data collection method was a SOAPP questionnaire that consisted of 14
questions. The questionnaire addresses history of alcohol or drug abuse, craving of
medication, mood swings, legal problems, and smoking (Akbik et al., 2006).
Procedures
I took the day’s scheduled appointments and performed a medical chart review on
adult patients between the ages of 30 and 65 who were currently prescribed opioid
medications. Charts were flagged so the intake staff knew to alert me to do a screening
interview with the patient using the SOAPP questionnaire. The score and results were put
into the patient chart for the physician to review. There was a separate card that the
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physician completed noting the score of the SOAPP and whether this information actually
modified the plan of care, either through alternative prescribing, detailed education, or a
monitoring plan.
Protections
While study participants were identified by their name in the chart, this was held
in strict confidence. All questionnaires were conducted in the exam room to ensure
confidentiality, and the data was limited to the physician and nurse practitioner. The data
form from the physician noting the score and whether they modified the plan of care did
contain identifying information. I used this information to construct a database for analysis
using descriptive statistics. This practice improvement project is adding to the normal
assessment of patients in this particular practice for use by the physician and therefore did
not require the patient’s consent. This proposal was submitted to the IRB for approval
(approval # 01-13-17-0533125).
Analysis and Synthesis
The analysis and synthesis of evidence addressed the practice focused question of
whether the use of the SOAPP screening was helpful for clinicians in identifying patients
who were at risk for aberrant behavior associated with receiving opioids to manage their
pain. The system used to record the data that was obtained from the SOAPP questionnaire
was the eClinicalWorks 10. The eClinicalWorks 10 is an electronic medical record that is
used in this practice for daily operations. This system allows data to be stored in a safe and
secure place and only accessible by individuals with a secure user ID and password.
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The data was scored using the Likert Scale of 0 = Never, 1= Seldom, 2 = Sometimes, 3 =
Often, 4 = Very Often, to determine if the patients were at low or high risk for opioid misuse
or abuse. Once the summary of the score was obtained, the results were placed in
eClinicaWorks 10 secure notes for review or modification of their plan of care. The secure
notes are only accessible to the physician and the nurse practitioner who are currently
managing their pain. The questionnaire was given orally and scored by me to help minimize
errors and missing data.
Summary
The main focus of this study was to explore the use of evidence-based practice
tools to address the process of solving the problem of opioid abuse and misuse by
patients. The study may provide additional information in the identification of risks for
those who are receiving prescribed medication from a physician or nursing practitioner.
Opioid abuse is not only a patient problem but a problem for all of society due of the
extreme nature of events that have occurred from overprescribing of opioids and the toll it
has taken on families and within communities. Section 4 will detail the findings and
recommendations.
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Section 4: Findings and Recommendation
Introduction
There has been an increase in abuse and misuse of opioid prescriptions by chronic
pain patients in the Unied States (Manworren & Gilson, 2015). Overprescribing of
opioids for pain management has contributed to a noticeable increase in opioid addiction
and death caused by overdose and heroin use (Kolodny et al., 2015). The shortage of
physicians specializing in pain management has contributed to ineffective opioid
prescribing practices and either misuse or abuse (Harle et al., 2015). The practice focused
question for this study was: Does the utilization of an evidence-based screening tool assist
the clinician in an out-patient pain management setting in identifying chronic pain patients
who are either at-risk of or who are abusing or misusing opioids, and does it result in a
modification of routine therapy? The purpose of this project involved the need to
implement evidence-based screening measures for opioid abuse and misuse for chronic
pain patients who take opioids to manage their pain.
The data collection method was the SOAPP questionnaire that consists of 14
questions. The questionnaire addresses history of alcohol or drug abuse, craving of
medication, mood swings, legal problems, and smoking, (Akbik et al., 2006). The scoring
is based on a Likert-5-point scale of 0 (Never), 1 (Seldom), 2 (Sometimes), 3 (Often), 4
(Very Often). The cut-off value is 7; the score of 7 or above indicates a high risk for abuse
and the need for additional monitoring for treatment for opioid therapy (Akibik et al.,
2006).
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SOAPP was developed with a grant from the National Institutes of Health and an
educational grant from Endo Pharmaceuticals (Inflexxion, 2008). It was designed based on
an expert consensus model to help clinicians identify those patients who may require
monitoring while on opioid therapy.
One hundred consecutive patients who presented at the medical practice were adult
patients between the ages of 25 and 65 who were currently prescribed opioid medications.
The SOAPP questionnaire was orally presented to the patients by this author at the time of
their scheduled appointment and prior to the clinicians entering the room. The results were
scored using a Likert 5-point scale of 0 (Never), 1 (Seldom), 2 (Sometimes), 3 (Often), 4
(Very Often). The cut-off value is 7; anything below 7 is considered low risk and the score
of 7 or above indicates a high risk for abuse and does require additional monitoring for
treatment for opioid.
Finding and Implications
The data collected from the SOAPP screening assessment tool found that 25% of
the interviewed participants scored at high risk (over the 7 cut-off value) for opioid misuse
and may require additional monitoring by the physician and nurse practitioner. The
patients identified as high risk were recommended for close monitoring by the clinician
and the results were used to aid in the development of a treatment plan that would avoid
the use of addictive interventions that could promote misuse. Findings were consistent
with Butler (2010) in regards to the SOAPP tool being an effective tool in identifying
patients at risk for abuse and providing awareness so problems can be addressed.
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The descriptive analysis includes both males and females between the ages of 25
and 65. The mean age for high risk was 51 and for low risk 54. Twenty two percent (22%)
of females and 27% of males scored at high risk. When divided into age groups, risk
appeared to increase with age in males and females, although the low number of
participants by age group is not statistically significant. This is consistent with the HHS
(2015) statistics noting that those aged 45-54 were at highest risk for opioid abuse.

Table 1
Patients Scoring Over 7 by Age and Sex
Number of persons
in this category
Categories

Number scoring 7
and above

Percentage scoring
7 and above

Male <35

7

1

Male 36-49

17

5

29%

Male >50

31

9

29%

Female <35

2

2

100%

13

2

15%

30

6

20%

Female 36-49
Female >50

14%
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A review of individual questions showed that the most significant questions that
pointed to risk factors were related to addictive behaviors, family history, and drug
screening. Table 2 provides information on those ranking at risk by question.
Table 2
Percentage Scoring 7 (n = 25) and Above by Individual Question
Questions
1. How often do you have mood swings?

Percentage Average Response 7 and above
88%

2. How often do you smoke a cigarette within an
hour after you wake up?

84%

3. How often have any of your family members,
including parents and grandparents, had a problem
with alcohol or drugs?

56%

4. How often have any of your close friends had a 40%
problem with alcohol or drugs?

5. How often have others suggested that you have a
drug or alcohol problem?

16%

6. How often have you attended an AA or NA
meeting?

32%

7. How often have you taken medications other than
the way that it was prescribed?

16%

8. How often have you been treated for an alcohol
or drug problem?

24%

9. How often have your medications been lost or
stolen?

2%
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10. How often have others expressed concern over 12%
your use of medication?
11. How often have you felt a craving for
medication?

12%

12. How often have you been asked to give a urine
screen for substance abuse?

60%

13. How often have you used illegal drugs (for
example, marijuana, cocaine, etc.) in the past five
years?

32%

14. How often, in your lifetime, have you had legal
problems or been arrested?

52%

A more detailed analysis of the four top questions in Table 3 revealed these
questions were more strongly associated with both males and females over 50. Further
study is needed on other factors such as longevity of opioid use and the acuity of chronic
pain in older adults.

Table 3
Percent at Risk by Question, Sex, and Age
Question
Males Males Males
<35
36-49 >50
Mood Swings
Cigarette within an
hour of waking up

4%
4%

20%
20%

24%
32%

Femal
es <35

Femal
Femal
es 3649 es 50>

8%
8%

8%

24%

8%

12%
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Family Members with 4%
substance abuse
issues

4%

20%

4%

4%

20%

Urine drug screen

12%

20%

8%

4%

12%

4%

Patient Response
I found that the patients were receptive to the score outcome whether it was high or
low. Many patients agree with the score and were not really surprised with their results.
However, the MD was surprised at some of the results. The implication for this practice is
that the introduction of a reliable tool to assess a patient’s risk of potential abuse or misuse
of opioids can aid in the development of an individualized plan of care for pain
management. The findings increased the awareness of potential risk to the nurse
practitioner (NP) and MD, resulting in their altering the plan of care of all those who
scored high risk. Modifications included more frequent visits, medication logs, and
intermittent urine testing.
The results from the screening tool can be used to educate the patient on risk
factors of opioid abuse and allow the patient to become more involved in their plan of
care. Patient involvement provides an opportunity for them to contribute to the
effectiveness and success of their pain management treatment plan. This office will
continue to utilize this tool in their practice.
The significance of using a simple screening tool such as SOAPP can have a
positive impact on social change by reducing opioid abuse and, in the long run, prevent
aberrant drug associated behavior. The misuse of prescription drugs continues to have a
significant impact on communities throughout the country (BJA, 2015). Communities are
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being targeted for criminal behaviors that are associated with prescription drug abuse and
misuse, including home and business burglaries and robberies of pharmacies, clinics, and
doctors’ offices. This has affected every community on the local, state, national, and
global level, necessitating interventions to help alleviate the drug dependency (BJA,
2015).
The implications for nursing practice include the utilization of screening tools by
the nurse practitioner who sees patients with chronic pain and the inclusion of patients into
the discussion of risk and the plan of care. Nurses need to be informed about the risks of
opioid use and addiction potential. The goal is to provide optimal pain management while
addressing the issues that may lead to addiction.
Recommendations
Several pain management centers measure risk by using only one of the
evidencebased tools to predict and assess probable risk of abuse when recommending
opioids for pain (Moore et al., 2009). It is recommended that risk assessment screening
tools be used on a regular basis in combination with cross-validation. For example, the
SOAPP results indicating a patient is at high risk of abusing opioids can be compared with
the patient’s urine results to validate the patient is currently misusing or abusing opioids.
This author recommends that the patients be included in the discussion of the results to
make them aware of their potential risk of opioid abuse or misuse and involve them in
their plan of care.
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Strength and Limitations of the Project
The major strength of this project is that the SOAPP instrument is a questionnaire
which is simple, free and easy to use and takes less than eight minutes to complete and
only one minute to score. This makes it a very practical screening tool to use, even for
large clinical settings. It is voluntary and non-invasive. The truthfulness and honesty of the
patient’s responses has an impact on the validity of the findings and is a limitation to using
this screening tool alone. This study did not allow for comparison of the SOAPP tool
results with urine screenings, or other screening methods which would have strengthened
the findings. The SOAPP screening tool should not only be used with patients who are
being considered for long-standing opioid therapy for chronic pain. It could be used in
other settings such as hospitals or primary care physician offices. It can be used for other
prescribed addictive medications. Additional research utilizing the took
with cross validation measures is needed.
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Section 5: Dissemination Plan
The dissemination plan for this private practice pain management clinic is that I
will give an oral presentation to the nurse practitioner and physician. Any high-risk
patients will have their treatment and plan of care monitored more closely to help avoid
the potential for misuse or abuse. The SOAPP questionnaire that was used in this project
to identify low or high risk patients will be scanned into a secure file for storage. I plan to
submit my abstract to National Institute on Drug Abuse regional meeting.
Analysis of Self
As a nurse practitioner, I have learned to be a strong advocate for change. And, as
an advocate and implementing change, I can have a significant impact on our society. I
can increase the chances of a patient having a better quality of life by incorporating
evidence-based research, recommendations, and guidelines that have been scientifically
proven to be beneficial. As a scholar, I have learned that a holistic approach to everyday
practice should be used to monitor and treat patients based on individual need
assessments.
This practical experience has given me a wealth of knowledge as a researcher, but
it has also had an impact on my personal and professional growth. It has allowed me
insight on a first-hand basis into situations that have been experienced by people in real
life. This has enlightened and refocused my long-term professional goals of opening a
much-needed rehabilitation center in a rural setting for people who are unable to afford the
help they desperately need due to cost and availability.
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As with most projects, there are challenges such as finances, transportation,
honesty, manipulation, noncompliance, and education. People in the healthcare profession
must face the challenges with integrity, knowledge, and available resources, and try to
treat everyone with dignity and respect. Although I may not have traveled the roads others
have traveled or encountered their struggles, as a professional, I promise to be a strong
leader, advocate, educator, resource, therapist, and nurse practitioner who is willing to
make a difference through change, caring, and hope.
Summary
With the ongoing trend of opioid abuse and misuse, it is essential that monitoring
programs be put in place to help reduce the problem. These monitoring programs can help
physicians and nurse practitioners become more aware of patients who may have
difficulty controlling their own medical use of opioids and who may require more
monitoring and management to avoid the potential for abuse or misuse of opioids today.
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Appendix A: Screener and Opioid Assessments for Patients with Pain (SOAPP)

SOAPP VERSION 1.0-14Q

Name: ___________________________________________ Date: _______________
The following are some questions given to all patients at the Pain Management Center
who are on or being considered for opioids for their pain. Please answer each question
as honestly as possible. This information is for our records and will remain
confidential. Your answers alone will not determine your treatment. Thank you.
Please answer the questions below using the following scale:
0 = Never, 1 = Seldom, 2 = Sometimes, 3 = Often, 4 = Very Often

1. How often do you have mood swings?

0 1 2 3 4

2. How often do you smoke a cigarette within an hour after
you wake up?

0 1 2 3 4

3. How often have any of your family members, including parents
and grandparents, had a problem with alcohol or drugs?

0 1 2 3 4

4. How often have any of your close friends had a problem with
alcohol or drugs?

0 1 2 3 4

5. How often have others suggested that you have a drug or
alcohol problem?

0 1 2 3 4

6. How often have you attended an AA or NA meeting?

0 1 2 3 4

7. How often have you taken medication other than the way that it
was prescribed?

0 1 2 3 4
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0 = Never, 1 = Seldom, 2 = Sometimes, 3 = Often, 4= Very Often

8.

How often have you been treated for an alcohol or drug problem?

0 1 2 3 4

9.

How often have your medications been lost or stolen?

0 1 2 3 4

10. How often have others expressed concern over your use
of medication?
11. How often have you felt a craving for medication?
12. How often have you been asked to give a urine screen
for substance abuse?

0 1 2 3 4
0 1 2 3 4

0 1 2 3 4

13. How often have you used illegal drugs (for example, marijuana, cocaine, etc.) in the
past five years?
0 1 2 3 4
14. How often, in your lifetime, have you had legal problems or
been arrested?

0 1 2 3 4

Please include any additional information you wish about the above answers. Thank you.
(Inflexxion, 2008).

©2008 Inflexxion, Inc. Permission granted solely for use in published format by
individual practitioners in clinical practice. No other uses or alterations are authorized or
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SOAPP® was developed with a grant from the National Institutes of Health and an
educational grant from Endo Pharmaceuticals.
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